EUVIMEDEUVIMED entdecken
Crossref

Genomic markers for enhanced risk stratification in Barrett's esophagus patients with Low-Drade Dysplasia

P. Stougie, N. F. Frei, V. Pappalardo, A. M. Khoshiwal, H. Yu, R. Menezes, L. C. Duits, J. Bergman, M. Stachler

Endoscopy · 01.04.2024 · 56 (S 02 S 02) · S78

DOI: 10.1055/s-0044-1782857 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.04.2024. Verfasst von P. Stougie und 8 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Current risk stratification of Barrett's esophagus (BE) patients, based on histological identification of dysplasia, lacks reliability due to poor interobserver agreement and the limited predictive value of low-grade dysplasia (LGD). This study aims to identify genomic factors enhancing risk stratification for BE patients with a community diagnosis of LGD.

Methods

Progressors to early esophageal adenocarcinoma and non-progressors were identified in a randomized controlled trial screening cohort of community-based LGD patients. Sequencing used a targeted capture-based panel to detect mutations and copy number changes (CNV). Detected mutations, homozygous deletions, and high-level amplifications underwent filtering for likely pathogenic events. We performed logistic regression, covariate analysis, and penalized mixed-effect models. A joint model for survival and mixed effects was applied for spatiotemporal data analysis.

Results

220 samples, comprising 28 progressors with a median time to progression of 1.2 (IQR 0.4-2.2) years and 95 non-progressors with a median progression-free follow-up of 7.9 (IQR 5.9-10.6) years, all with a median C3M5 BE, were analyzed. Multiple factors were associated with progression, including TP53 (p 3 mutations had a very high risk of progression (HR=10.33, 95% CI 2.22-48.01). Presence of any genetic variant—amplification, deletion, CNV, or mutation— indicated progression risk (p

Zitieren

APA

Stougie, P., Frei, N. F., Pappalardo, V., Khoshiwal, A. M., Yu, H., Menezes, R., Duits, L. C., Bergman, J., & Stachler, M. (2024). Genomic markers for enhanced risk stratification in Barrett's esophagus patients with Low-Drade Dysplasia. Endoscopy, 56(S 02 S 02), S78. https://doi.org/10.1055/s-0044-1782857

Vancouver

Stougie P, Frei NF, Pappalardo V, Khoshiwal AM, Yu H, Menezes R, et al. Genomic markers for enhanced risk stratification in Barrett's esophagus patients with Low-Drade Dysplasia. Endoscopy. 2024;56(S 02 S 02):S78. doi:10.1055/s-0044-1782857

BibTeX
@article{Stougie2024,
  author = {Stougie, P. and Frei, N. F. and Pappalardo, V. and Khoshiwal, A. M. and Yu, H. and Menezes, R. and Duits, L. C. and Bergman, J. and Stachler, M.},
  title = {Genomic markers for enhanced risk stratification in Barrett's esophagus patients with Low-Drade Dysplasia},
  journal = {Endoscopy},
  year = {2024},
  volume = {56},
  number = {S 02 S 02},
  pages = {S78},
  doi = {10.1055/s-0044-1782857}
}
Kostenlos starten →